ctrl K

Watchlist Price Alert

Clarus Therapeutics Inc. (CRXT)

NASDAQ: CRXT · Real-Time Price · USD

0.05

-0.02 (-27.54%)

At close: Sep 06, 2022, 7:59 PM

Clarus Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020
Period Ending	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
Revenue	4.05M	4.01M	6.89M	4.29M	2.78M	n/a	n/a	2.22M
Cost of Revenue	1.16M	664K	1.66M	510K	554K	n/a	n/a	257K
Gross Profit	2.89M	3.35M	5.24M	3.78M	2.23M	n/a	n/a	1.97M
Operating Income	-8.67M	-12.9M	-13.16M	-8.43M	-13.24M	10.65M	-8.16M	-11.24M
Interest Income	n/a	1K	1K	1K	n/a	n/a	n/a	1K
Pretax Income	-10.69M	-14.87M	-19.73M	-2.77M	-18.11M	10.65M	n/a	5.41M
Net Income	-12.71M	-16.84M	-26.3M	-2.77M	-18.11M	10.65M	n/a	5.41M
Selling & General & Admin	12.31M	16.01M	21.55M	10.93M	14.86M	n/a	2.98M	11.77M
Research & Development	1.23M	881K	1.75M	1.27M	606K	n/a	n/a	1.44M
Other Expenses	n/a	n/a	n/a	n/a	n/a	10.65M	n/a	n/a
Operating Expenses	13.54M	16.89M	23.3M	12.21M	15.46M	10.65M	2.98M	13.21M
Interest Expense	2.02M	1.97M	6.57M	4.45M	4.88M	n/a	n/a	4.29M
Selling & Marketing Expenses	6.69M	10.73M	13.6M	7.55M	9.53M	n/a	n/a	8.73M
Cost & Expenses	14.7M	17.56M	24.95M	12.72M	16.02M	10.65M	2.98M	13.47M
Income Tax Expense	2.02M	1.97M	6.57M	10.11M	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	9.15M	9.15M	9.15M	9.15M	21.73M	3.48M	4.46M	21.73M
Shares Outstanding (Diluted)	9.15M	9.15M	9.15M	9.15M	21.73M	3.77M	4.46M	21.73M
EPS (Basic)	-1.39	-1.84	-2.87	-0.3	-0.83	3.06	n/a	0.25
EPS (Diluted)	-1.39	-1.84	-2.87	-0.3	-0.83	2.83	n/a	0.25
EBITDA	-10.65M	-13.55M	-9.92M	1.7M	-894.64K	n/a	-8.16M	9.7M
EBIT	-6.7M	-12.9M	-13.16M	1.68M	n/a	n/a	n/a	9.7M
Depreciation & Amortization	7K	7K	7K	18K	55.81K	55.21K	55.13K	20.94M